āshibio Doses First Patient in ANDECAL study, a Phase 2/3 Trial of Andecaliximab for Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
BRISBANE, Calif., January 23, 2025--āshibio, a privately held, clinical-stage biotechnology company developing novel ...
FOX 40 WICZ TV6d
ashibio Doses First Patient in ANDECAL study, a Phase 2/3 Trial of Andecaliximab for Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
“People living with FOP lack adequate treatment options, and dosing of the first participant in the ANDECAL trial is a significant milestone in our mission to address their needs. Andecaliximab ...
Columbus Dispatch5d
Ohio Fraternal Order of Police honoring 2 central Ohio officers for heroic 2024 actions
FOP Ohio President Jay McDonald, whose organization represents more than 23,000 law enforcement members statewide, said the quick thinking of both officers saved two lives. "The Fraternal Order of ...
Woman indicted in crash that killed Vikings rookie Khyree Jackson, 2 others
Minnesota Vikings rookie cornerback Khyree Jackson ...